Customized Peptide Synthesis Market Size to Reach $390

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
40
Customized Peptide Synthesis Market Size to Reach $390 Million by 2024: P&S Intelligence

Customized Peptide Synthesis Market by Product (Reagents, Equipment [Peptide Synthesizers, Chromatography Equipment, Lyophilizers]), by Application (Commercial [Antibody Production, Drug Discovery, Enzyme Profiling], Academic Research [Disease Research, Biomarker Discovery]), by Technology (SPPS, SPS, Hybrid & Recombinant Technology), by End User (Pharmaceutical & Biotechnology Companies, CMOs & CROs, Academic & Research Institutes), by Geography (U.S., Canada, Germany, France, U.K., Italy, Spain, China, Japan, India, South Korea, Singapore, Brazil, Mexico, Israel, South Africa, Saudi Arabia) – Global Market Size, Share, Development, Growth, and Demand Forecast, 2014–2024

NEW YORK, Jan. 24, 2019 (GLOBE NEWSWIRE) -- According to the market research report published by P&S Intelligence, customized peptide synthesis market is forecasted to generate revenue of $390.0 million by 2024. The market is mainly driven by increasing investments and funding for protein-based research, technological innovations, growing burden of cancer and infectious diseases, and increasing research activities in the field of synthetic biology.

Request to get the sample pages of the report: https://www.psmarketresearch.com/market-analy...ort-sample

The different types of products available in the customized peptide synthesis market are reagents and equipment. Reagents category is expected to observe faster growth in demand, witnessing a CAGR of 6.8% during the forecast period. This growth can be attributed to the high usage of a wide range of reagents including substrates, additives, buffers, precipitation agents, and others for the purpose of peptide synthesis.

Among the various applications, commercial application is the fastest growing category in the customized peptide synthesis industry, demonstrating a CAGR of 6.9% during the forecast period. The recent advancements in chemical peptide synthesis and inclusion of modified amino acids have increased the commercial potential of customized peptides.

Based on technology, SPPS technology is predicted to be the fastest growing technology in the global market in the coming years, advancing at a CAGR of 6.9% during 2019-2024. As compared to SPS, this technology has high efficiency and throughput screening, with greater simplicity and speed for the production of peptides.

Browse report overview with 347 tables and 54 figures spread through 295 pages and detailed TOC on "Customized Peptide Synthesis Market" at: https://www.psmarketresearch.com/market-analy...sis-market

Pharmaceutical and biotechnology companies as an end-user category is predicted to witness fastest growth in the customized peptide synthesis market, registering a CAGR of 6.8% during the forecast period. This growth is mainly due to extensive research and large production of peptides by pharma and biotech companies across the globe.

During the forecast period, customized peptide synthesis market in APAC is expected to witness the fastest growth, observing a CAGR of 7.9%. The growth in the market is mainly led by the increasing use of peptides in drug discovery, low cost of raw materials, technological advancements, increasing life sciences research activities, and availability of funds for research and development.

Globally, the customized peptide synthesis market is witnessing rapid evolution with the development and launch of new peptide-based products. For instance, in September 2018, Biotage AB launched its new Alstra remote software, which enables the users to program the peptide synthesis setup offline, subsequently import peptide sequences, and then execute the synthesis on Initiator + Alstra.

Make enquiry before buying the report: https://www.psmarketresearch.com/send-enquiry...sis-market

Moreover, various research institutes are actively involved in advanced research activities related to peptide synthesis. For example, in February 2017, researchers at the Massachusetts Institute of Technology (MIT) designed a machine that can rapidly produce large quantities of customized peptides. The machine can form links between amino acids in about 37 seconds and can generate peptide molecules (containing up to 60 amino acids) in less than an hour. Hence, the market is witnessing evolution on account of new product launches and advanced research.

Some of the other key players operating in the customized peptide synthesis industry are GenScript Biotech Corporation, Bachem AG, Thermo Fisher Scientific Inc., AAPPTec LLC, Advanced ChemTech, AnaSpec Inc., New England Peptide Inc., Rockland Immunochemicals Inc., INTAVIS Bioanalytical Instruments AG, and JPT Peptide Technologies GmbH.

More Reports by P&S Intelligence

Molecular Cytogenetics Market

During the forecast period, the molecular cytogenetics market is projected to witness fastest growth in APAC, at CAGR of 11.8%, mainly due to the large population in the region, untapped market and entry of global players in the industry to offer cytogenetic testing. Government initiatives such as mandatory testing, funding and training programs to the researchers are some other factors that are propelling the growth of the market in the region.

https://www.psmarketresearch.com/market-analy...ics-market

Cell Isolation Market

During the forecast period, the cell isolation market is projected to witness the fastest growth in APAC, with a CAGR of 22.1%. This is due to the increasing focus on basic and applied research by countries in the region. Besides, countries such as India and China have established research institutes promoting cell-based research. Hence, advanced healthcare infrastructure, rising adoption of innovative cell isolation products, and high demand for regenerative medicines are expected to drive the market growth in APAC in the coming years.

https://www.psmarketresearch.com/market-analy...ion-market

About P&S Intelligence

P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Contact:

P&S Intelligence

Toll-free: +1-888-778-7886 (USA/Canada)

International: +1-347-960-6455

Email: enquiry@psmarketresearch.com

Web: https://www.psmarketresearch.com

Connect with us: LinkedIn  |  Twitter  |  Google +  |  Facebook

Scroll down for more posts ▼

Top 10 Most Recent News Articles

UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 3

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 6

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 1

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 0

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 5

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 0

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 2

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading

Top 5 Most Recently Viewed Articles

EEW Renewables and CDAQ Plan Major Business Move Together

Updated Category News Views 57

EEW Renewables and CDAQ Unveil Investor Webcast for Business Combination EEW Renewables Ltd, a leader in the renewable energy sector, has teamed up with Compass Digital Acquisition Corp, commonly known as CDAQ, to announce the release of an investor webcast aimed at discussing their proposed business combination. The webcast features insightful presentations from the...

Continue Reading
Investors Can Take Action in Integer Holdings Lawsuit Today

Updated Category News Views 131

Opportunities for Integer Holdings Investors Recently, Integer Holdings Corporation (NYSE: ITGR) has opened the door for investors to engage actively in a securities fraud lawsuit. This comes as the Rosen Law Firm, known for its expertise in investor rights, brought attention to a class action concerning common stock purchases made between July 25, 2024 and October 22,...

Continue Reading
Controversial Legal Battle Unfolds at FNZ Amid Equity Tensions

Updated Category News Views 365

FNZ Directors Face Employee Shareholder Backlash In a surprising twist in the ongoing legal saga surrounding FNZ, the two directors representing major shareholders have taken significant steps to impede a USD $4.6 billion class action initiated by employee shareholders. This action raises serious concerns about corporate governance and the rights of employees within the...

Continue Reading
Unity in the Cannabis Industry: A New Path Forward

Updated Category News Views 88

Time for Unity in the Cannabis Industry Recent changes in the hemp and cannabis industries have underscored how vital collaboration is. Experts in the field are pushing for a stronger partnership between these sectors to advocate for clear and coherent federal regulations. The Current Situation Tensions are rising across several states. For instance, Florida's hemp...

Continue Reading
Daiso Launches New Store in San Antonio's Shopping Hub

Updated Category News Views 314

Exciting New Daiso Store Opening Daiso, a global retail sensation, is set to debut its latest store at Thousand Oaks Shopping Center. This opening is generating buzz among shoppers looking for affordable and unique merchandise. The store is designed to cater to a diverse range of tastes and needs, and it's perfectly timed for the upcoming shopping season. Store Features...

Continue Reading